Mark Alles Sample Contracts

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies
officer: See Remarks until July 31st, 2013
Celgene Corp /De/ – Name S.J. Rupert Vessey Job Title President, Research & Early Development Base Salary $675,000 Effective January 8, 2016 Bonus Target 70% Effective January 8, 2016 Annual Equity Award Stock Options Restricted Stock Units Effective February 9, 2016 51,624 6,731 Performance Equity Stock Options Restricted Stock Units Effective October 18, 2016 18,304 5,369 Cash Long-Term Incentive Plan Threshold Target Maximum Effective December 15, 2015 $287,500 $575,000 $1,150,000 Severance Benefit Lump sum 12 months of base salaryLump sum 12 months of bonus at target12 months COBRA benefit at active employee (February 10th, 2017)
Celgene Corp /De/ – [CELGENE GRAPHIC OMITTED] Contact: Robert J. Hugin Brian P. Gill Senior VP and CFO Director of PR/IR Celgene Corporation Celgene Corporation (732) 271-4102 (732) 652-4530 CELGENE CORPORATION REPORTS RECORD OPERATING PERFORMANCE IN FIRST QUARTER WITH STRONG REVENUE GROWTH AND PROFITS First Quarter Results: ---------------------- o FIRSTo QUARTER REVENUES INCREASED 68.8% VERSUS THE YEAR AGO QUARTER, DRIVEN BY STRONG THALOMID(R) AND ALKERAN(R) PERFORMANCE o QUARTERLY DILUTED EARNINGS PER SHARE INCREASED TO $0.10 FROM $0.01 IN THE YEAR- AGO QUARTER. o KEY REVLIMID(TM) MULTIPLE MYELOMA REGULATORY TR (April 22nd, 2004)